General MedicationsORALStandard

ESCITALOPRAM OXALATE

Standard Dose

EQ 10MG BASE

Max Dose

Refer to approved labeling

Primary Use

Review priority: STANDARD Marketing status: Prescription

Summary

Approval overview ESCITALOPRAM OXALATE is listed in Drugs@FDA under application 215177 (ANDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient ESCITALOPRAM OXALATE Form and strength TABLET;ORAL - EQ 10MG BASE Sponsor ASCENT PHARMS INC Submission history Latest submission status date: 2025-07-15 00:00:00.

Structured Monograph

Clinical summary

Approval overview ESCITALOPRAM OXALATE is listed in Drugs@FDA under application 215177 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient ESCITALOPRAM OXALATE Form and strength TABLET;ORAL - EQ 10MG BASE Sponsor ASCENT PHARMS INC Submission history Latest submission status date: 2025-07-15 00:00:00. Submission type: ORIG.

Monitoring

• Marketing status: Prescription
• Review priority: STANDARD

Interaction Notes

No interaction notes stored yet.